151. ラスムッセン脳炎 Rasmussen encephalitis Clinical trials / Disease details
臨床試験数 : 2 / 薬物数 : 4 - (DrugBank : 2) / 標的遺伝子数 : 6 - 標的パスウェイ数 : 86
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04003922 (ClinicalTrials.gov) | October 20, 2020 | 20/6/2019 | Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term | Observational Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term | Rasmussen Encephalitis | Other: Adalimumab treatment | Assistance Publique Hopitaux De Marseille | NULL | Recruiting | 2 Years | N/A | All | 40 | France |